150 related articles for article (PubMed ID: 3612391)
1. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment.
Pitchford KC; Corey M; Highsmith AK; Perlman R; Bannatyne R; Gold R; Levison H; Ford-Jones EL
J Pediatr; 1987 Aug; 111(2):212-6. PubMed ID: 3612391
[TBL] [Abstract][Full Text] [Related]
2. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
[TBL] [Abstract][Full Text] [Related]
3. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
Jakobsson B; Hjelte L; Nyström B
J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations.
Tabatabaii SA; Khanbabaee G; Sadr S; Farahbakhsh N; Aghdam MK; Lotfollahzadeh S; Hosseini A; Dara N; Nanbakhsh M; Gorji FA
BMC Pulm Med; 2020 Feb; 20(1):33. PubMed ID: 32028925
[TBL] [Abstract][Full Text] [Related]
5. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
[TBL] [Abstract][Full Text] [Related]
6. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients.
Jakobsson BM; Onnered AB; Hjelte L; Nyström B
J Hosp Infect; 1997 Jul; 36(3):201-7. PubMed ID: 9253701
[TBL] [Abstract][Full Text] [Related]
7. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.
Riquena B; Monte LFV; Lopes AJ; Silva-Filho LVRFD; Damaceno N; Aquino EDS; Marostica PJC; Ribeiro JD
J Bras Pneumol; 2019 May; 45(3):e20170351. PubMed ID: 31166553
[TBL] [Abstract][Full Text] [Related]
8. Frequency of contamination of single-patient-use nebulizers over time.
Weber DJ; Gergen MF; Sickbert-Bennett EE; Short KA; Lanza-Kaduce KE; Rutala WA
Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1543-6. PubMed ID: 25419779
[TBL] [Abstract][Full Text] [Related]
9. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
10. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis.
Burdge DR; Nakielna EM; Noble MA
Infect Control Hosp Epidemiol; 1993 Mar; 14(3):127-30. PubMed ID: 7683031
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of efficacy of 5 methods of disinfection on mouthpieces and facemasks contaminated by strains of cystic fibrosis patients.
Reychler G; Aarab K; Van Ossel C; Gigi J; Simon A; Leal T; Lebecque P
J Cyst Fibros; 2005 Sep; 4(3):183-7. PubMed ID: 16046195
[TBL] [Abstract][Full Text] [Related]
12. Importance of Nebulizer Drying for Patients With Cystic Fibrosis.
Moore JE; Moore RE; Bell J; Millar BC
Respir Care; 2020 Oct; 65(10):1443-1450. PubMed ID: 32209705
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment.
Jensen ET; Giwercman B; Ojeniyi B; Bangsborg JM; Hansen A; Koch C; Fiehn NE; Høiby N
J Hosp Infect; 1997 Jun; 36(2):117-22. PubMed ID: 9211158
[TBL] [Abstract][Full Text] [Related]
14. Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection.
Greenwood J; Schwarz C; Sommerwerck U; Nash EF; Tamm M; Cao W; Mastoridis P; Debonnett L; Hamed K
Ther Adv Respir Dis; 2017 Jul; 11(7):249-260. PubMed ID: 28614995
[TBL] [Abstract][Full Text] [Related]
15. Home nebulizer use among patients with cystic fibrosis.
Rosenfeld M; Emerson J; Astley S; Joy P; Williams-Warren J; Standaert TA; Yim DL; Crist D; Thykkuttathil M; Torrence M; FitzSimmons S; Ramsey B
J Pediatr; 1998 Jan; 132(1):125-31. PubMed ID: 9470013
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.
Thomassen MJ; Demko CA; Klinger JD; Stern RC
Am Rev Respir Dis; 1985 May; 131(5):791-6. PubMed ID: 3923882
[TBL] [Abstract][Full Text] [Related]
17. Microbial colonization of nebulizers used by asthmatic children.
Cohen HA; Kahan E; Cohen Z; Sarrell M; Beni S; Grosman Z; Ashkenazi S
Pediatr Int; 2006 Oct; 48(5):454-8. PubMed ID: 16970782
[TBL] [Abstract][Full Text] [Related]
18. Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.
Della Zuana A; Garcia Dde O; Juliani RC; Silva Filho LV
J Bras Pneumol; 2014; 40(2):119-27. PubMed ID: 24831395
[TBL] [Abstract][Full Text] [Related]
19. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
[TBL] [Abstract][Full Text] [Related]
20. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.
Hutchinson GR; Parker S; Pryor JA; Duncan-Skingle F; Hoffman PN; Hodson ME; Kaufmann ME; Pitt TL
J Clin Microbiol; 1996 Mar; 34(3):584-7. PubMed ID: 8904419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
